BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2014 8:57:00 PM | Browse: 622 | Download: 646
Publication Name World Journal of Meta-Analysis
Manuscript ID 6659
Country/Territory Italy
Received
2013-10-26 12:38
Peer-Review Started
2013-10-27 12:48
To Make the First Decision
2013-11-19 12:54
Return for Revision
2013-11-19 17:46
Revised
2013-11-20 00:37
Second Decision
2013-12-19 12:59
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-12-19 13:19
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2013-12-30 04:21
Typeset the Manuscript
2014-02-18 18:06
Publish the Manuscript Online
2014-02-26 18:57
ISSN 2308-3840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac and Cardiovascular Systems
Manuscript Type Review
Article Title Role of nuclear cardiology for guiding device therapy in patients with heart failure
Manuscript Source Invited Manuscript
All Author List Mario Petretta, Andrea Petretta, Teresa Pellegrino, Carmela Nappi, Valeria Cantoni and Alberto Cuocolo
Funding Agency and Grant Number
Corresponding author Mario Petretta, MD, Department of Translational Medical Sciences, University of Naples Federico Ⅱ, Via Pansini 5, 80131 Naples, Italy. petretta@unina.it
Keywords Heart failure; Cardiac resynchronization therapy; Implantable cardioverter defibrillators; Cardiovascular imaging; Single-photon emission-computed tomography; Positron emission tomography; Metaiodobenzylguanidine
Core Tip This article focuses on the potential capability of nuclear cardiology techniques to guide cardiac resynchronization therapy and to select patients for implantable cardioverter defibrillators. Radionuclide angiography and gated single-photon emission computed tomography myocardial perfusion imaging have shown promise as predictors of outcome after device therapies. Combined positron emission tomography/computed tomography may identify the location of biventricular pacemaker leads and obtain left ventricular functional data, including contractile phase analysis. Cardiac imaging with autonomic radiotracers may predict cardiac resynchronization therapy response and may also identify patients at risk for sudden cardiac death, therefore potentially offering a way to select patients for these device treatments.
Publish Date 2014-02-26 18:57
Citation Petretta M, Petretta A, Pellegrino T, Nappi C, Cantoni V, Cuocolo A. Role of nuclear cardiology for guiding device therapy in patients with heart failure. World J Meta-Anal 2014; 2(1): 1-16
Url http://www.wjgnet.com/2308-3840/full/v2/i1/1.htm
DOI http://dx.doi.org/10.13105/wjma.v2.i1.1
Full Article (PDF) WJMA-2-1.pdf
Full Article (Word) WJMA-2-1.doc
Manuscript File 6659-Review.doc
Answering Reviewers 6659-Answering reviewers.pdf
Copyright License Agreement 6659-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 6659-Language certificate.pdf
Peer-review Report 6659-Peer review(s).pdf
Scientific Editor Work List 6659-Scientific editor work list.doc